Ketamine-ECT Study

Affiliations

¹ VA Medical Center, Hampton, VA, 23667, USA; Eastern Virginia Medical School, Norfolk, VA, USA. Electronic address: william.mcdaniel@va.gov.
² VA Medical Center, Hampton, VA, 23667, USA.
³ VA Medical Center, Hampton, VA, 23667, USA; VA Medical Center Branch Clinic, Virginia Beach, VA, USA.

Comment

William McDaniel et al. Lancet Psychiatry. 2017 Sep.

. 2017 Sep;4(9):662.

doi: 10.1016/S2215-0366(17)30329-2.

¹ VA Medical Center, Hampton, VA, 23667, USA; Eastern Virginia Medical School, Norfolk, VA, USA. Electronic address: william.mcdaniel@va.gov.
² VA Medical Center, Hampton, VA, 23667, USA.
³ VA Medical Center, Hampton, VA, 23667, USA; VA Medical Center Branch Clinic, Virginia Beach, VA, USA.

No abstract available

Comment on

Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial.
Anderson IM, Blamire A, Branton T, Clark R, Downey D, Dunn G, Easton A, Elliott R, Elwell C, Hayden K, Holland F, Karim S, Loo C, Lowe J, Nair R, Oakley T, Prakash A, Sharma PK, Williams SR, McAllister-Williams RH; Ketamine-ECT Study team. Anderson IM, et al. Lancet Psychiatry. 2017 May;4(5):365-377. doi: 10.1016/S2215-0366(17)30077-9. Epub 2017 Mar 27. Lancet Psychiatry. 2017. PMID: 28359862 Free PMC article. Clinical Trial.